The Problem
Relaxo Footwears is in trouble. The company sold 43 million pairs in Q1 FY26, down 14% from 50 million last year. It's not unexpected when people cut back on extras. Rural and semi-urban shoppers face inflation, and Relaxo's core buyers in the under-500-rupee segment have the tightest budgets.
But the size of this drop is worrying. It raises real questions about whether Relaxo can hold onto market share as demand stays soft.
The GST Problem
The GST rate cut on footwear should help Relaxo. The catch is timing. Too much inventory built up under the old rate still clogging the distribution chain. Until that clears, the rate cut won't boost sales.
An inverted duty structure—input taxes higher than output taxes—keeps squeezing margins even with the lower GST rate.
Relaxo expects the inventory overhang to clear by Q3, when the lower rates should finally help volumes and pricing.
Regional Rivals Are Hitting Hard
Smaller regional competitors are coming after Relaxo with aggressive pricing in its core general trade channel. That's eroding Relaxo's hold on key markets, especially North and East India where it used to dominate.
Relaxo is fighting back with more brand investment and expanded distribution. The company is building direct relationships with retailers to cut out middlemen and get better control over shelf placement and pricing.
| Company | Avg. Price | Volume (M pairs) | Growth | Market Share |
|---|---|---|---|---|
| Relaxo | ₹285 | 43 | -14% | 22% |
| Bata | ₹520 | 35 | +4% | 18% |
| Paragon | ₹210 | 28 | +2% | 14% |
What's Ahead
We expect 3-4% growth in Q3 once inventory clears and the festive season kicks in. Bigger improvements probably come in Q4 and FY27, if farm incomes stabilize and rural buyers go back to spending.
Relaxo has real strengths. The brand is known, it has deep roots in smaller towns and cities, and the manufacturing is solid. The problem is simple: if rural customers don't start buying again, none of that matters.
Source: Company filings, Datum Intelligence analysis. This article is for informational purposes only and does not constitute investment advice.